PEStore

Other

EMR Capital

EMR Capital invests its own or fund capital, without a clearly stated strategy, from Hong Kong, China. It states a focus on materials & chemicals and industrials & manufacturing.

Disclosed holdings3
Earliest stated investment
HeadquartersHong Kong, China
Largest single fundNot stated

Regulatory record

How EMR Capital is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised8 · $622m gross
SEC adviser numberCRD 169370

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies EMR Capital lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Golden Grove (Australia)
Lubambe (Zambia)
Martabe (Indonesia)

Compiled from EMR Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Recorded transactions

Buying and selling

Deals in which EMR Capital is named as buyer or seller in the transaction archive. 1 recorded acquisition.

CompanySideCounterpartyYearConsideration
BHP Billiton - Cerro ColoradoBoughtBHP2018$320m

Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.

Valuation context

Transaction values in Materials & Chemicals

What companies have actually sold for in materials & chemicals, across 401 recorded transactions.

Median consideration$118m
Middle 50%$27m-$300m
Revenue multiple1.4×
EBITDA multiple7.85×

The full materials & chemicals picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a materials & chemicals business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this EMR Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other other investors active in materials & chemicals.